Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
about
A novel role for Wnt/Ca2+ signaling in actin cytoskeleton remodeling and cell motility in prostate cancerPC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesisComparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling dataEnglerin A stimulates PKCθ to inhibit insulin signaling and to simultaneously activate HSF1: pharmacologically induced synthetic lethalityTissue specific and androgen-regulated expression of human prostate-specific transglutaminaseReverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissueSuppressive roles of calreticulin in prostate cancer growth and metastasisMeasles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutininClinical and experimental progression of a new model of human prostate cancer and therapeutic approachExpression analysis of secreted and cell surface genes of five transformed human cell lines and derivative xenograft tumors.Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancerInvestigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma.Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDXEmerging mechanisms of resistance to androgen receptor inhibitors in prostate cancerAllogeneic tumor cell vaccines: the promise and limitations in clinical trialsChemoaffinity capture of pre-targeted prostate cancer cells with magnetic beadsTumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces.GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cellsPlumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cellsUnique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cellsAndrogens upregulate Cdc25C protein by inhibiting its proteasomal and lysosomal degradation pathwaysRole for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cellsAnti-neoplastic activity of two flavone isomers derived from Gnaphalium elegans and Achyrocline bogotensisConstitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancerLeuprorelin acetate long-lasting effects on GnRH receptors of prostate cancer cells: an atomic force microscopy study of agonist/receptor interactionEvaluating baculovirus as a vector for human prostate cancer gene therapyCompound A, a selective glucocorticoid receptor modulator, enhances heat shock protein Hsp70 gene promoter activationThe aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cellsDevelopment of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imagingCharacterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancerChemical composition, antioxidant, anti-inflammatory and anti-proliferative activities of essential oils of plants from Burkina FasoU19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasiaMicrosatellite-encoded domain in rodent Sry functions as a genetic capacitor to enable the rapid evolution of biological noveltyLoss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.Impact of adjustable cryogel properties on the performance of prostate cancer cells in 3DSki-interacting protein (SKIP) interacts with androgen receptor in the nucleus and modulates androgen-dependent transcription.Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressorRational design and characterization of a Rac GTPase-specific small molecule inhibitorDetection of Lymph Node Metastases with SERRS Nanoparticles.Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
P2860
Q21136388-B0B9B17B-BAC0-46D2-86B5-3CC072F1742FQ21245704-B38473B7-4CD3-4FCA-A583-5AE5EA7C2EFAQ21266587-003142B6-921B-4DBC-B261-8AA6F7F18643Q24311618-EFC77C6A-E151-4D8A-A4E5-B4395598645BQ24534258-E5F2BE73-3C03-4A3F-8683-068E09283440Q24614528-AF7BD519-DADE-477C-A85A-29B41EF1A826Q24643552-0A3E62C2-A512-4E11-931F-F9795695CBB2Q24655592-A2A69078-F125-4D18-A7A3-E3DD68D7648EQ24685731-6C8AB2A4-766B-4E40-9697-0F1EB9089302Q24803501-A61769BA-AE93-4698-A809-615E5B251370Q24807354-CD1EE7AF-D7F3-4C87-87B8-C5097E340C79Q24815816-92D0D03D-586B-494B-9F15-BA621A790415Q26746524-326CAABF-9696-4D75-BFFD-A73D294C9BD1Q26777310-72F7B5BA-C9C4-406D-A456-37E8056CB64FQ26852333-853CAF70-B78F-41A6-B89D-B5DF21B57757Q26861322-500B0271-B0E5-4DCE-A833-34E72C78E479Q27316928-F6BBF1EF-8DD6-42AE-8734-9B669AD18381Q28363395-F803FD55-0E50-4A02-88A2-8FB896C55C86Q28385880-45A82D9E-AEDF-46DA-8D5C-1F83C475B4E6Q28391298-CE62403C-343C-416B-951F-11F4F4E0B23AQ28397032-BDB3B90A-B877-4E10-83AD-56EBA7F528B4Q28472519-03DCC9AE-2EEB-4927-9FB0-340B292A64DDQ28480937-7F5F99CE-587A-4951-B9F5-490ADA5CA48AQ28483606-6FF8F3BF-4FC4-4664-A62A-0D061A459E83Q28484928-AB2F40D1-2451-47B1-B4DD-CB839A9EA4E0Q28533692-DF397E63-4766-460D-95B3-A7129D6109C6Q28534982-6D37F903-111C-4C31-B308-1400CDB549A6Q28538111-683A20A8-3B80-45D3-8222-1669FE4DC4A5Q28538391-99B4B237-C301-439F-A56F-245BF3D3169DQ28539356-F902D699-C980-4C37-B414-131060A48FAFQ28541371-E20AE14A-9D7D-44EA-99E7-0A9849D37FFCQ28590029-589A72DE-F825-40C9-854A-FF34710540DAQ28681825-9518C263-7BF8-412C-8F64-4E575222005AQ28730032-717B6BB4-397B-42FA-A371-A1ED263E9207Q28828719-D6AA8B44-4AB7-4412-A051-45E7F6F0FE2FQ28910351-BC8F5B65-4897-4E48-982E-0013DCB0C0ABQ29615559-88A26C54-5C83-4AB4-A9DA-13C7EA803DB1Q29616494-92B8F367-B1C3-446F-B37E-55672E490377Q30373357-7085FF4F-B79E-43B2-9929-69562233045FQ30438661-C364DE0F-B361-4CA3-8AC3-846AAD00C180
P2860
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
description
1979 nî lūn-bûn
@nan
1979 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
@ast
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
@en
Establishment and characterization of a human prostatic carcinoma cell line
@nl
type
label
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
@ast
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
@en
Establishment and characterization of a human prostatic carcinoma cell line
@nl
prefLabel
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
@ast
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
@en
Establishment and characterization of a human prostatic carcinoma cell line
@nl
P2093
P4510
P1476
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
@en
P2093
P577
1979-07-01T00:00:00Z